Sariya Banday: Optimizing BCMA CAR-T Cells to Improve Persistence and Reduce Exhaustion
Sariya Banday, Executive Board Member at University of Minnesota Rural Health Advocacy Network, shared a post on LinkedIn:
“I’m excited to share that my first-author abstract, ‘Nicotinamide and Vitamin C conditioning preserves an early-memory phenotype and limits exhaustion in BCMA CAR-T cells,’ has been accepted for poster presentation at the 2026 ASH Annual Meeting in New Orleans and received an ASH Abstract Achievement Award!
Over the summer I conducted research at the Medical College of Wisconsin Center for Cancer Discovery where I looked for ways to help BCMA CAR-T cells persist and resist exhaustion in multiple myeloma.
Through much determination, trial and error, and hard work, we successfully found that conditioning the cells with Vitamin C and Nicotinamide helped preserve an early-memory phenotype while limiting cell exhaustion.
I would like to extend my gratitude towards Sun, Rai, and everyone in lab for their guidance throughout this project.
Their mentorship made this possible.
I will be presenting on Sunday, December 13 in Hall F and if you are attending ASH, please stop by and say hello!”
Stay updated with Hemostasis Today.
-
Nov 11, 2026, 15:42Tareq Abadl: The Clinical Impact of Kell Alloimmunization
-
Nov 11, 2026, 15:30Alejandro González Veliz: Does PCI Change The Long-Term Outcome In Stable Coronary Artery Disease?
-
Nov 11, 2026, 15:25Preparing for the SoHO Regulation – EBA Board Convenes in Vienna – European Blood Alliance
-
Nov 11, 2026, 15:20Vaidehi Prasanth: IV Iron in Heart Failure – Exploring Hospitalisation Benefits vs. Infection Risk in Open Heart
-
Nov 11, 2026, 15:18Stefan Prendić: Can Algorithms Support Antibody Identification in Immunohematology?
-
Nov 11, 2026, 15:12Perioperative Challenges in Hemophilia Patients on Rebalancing Therapies
-
Nov 11, 2026, 15:03Maria Elisa Mancuso: World-Renowned Faculty and 33 Global Participants Unite at Hemophilia Academy 2026
-
Nov 11, 2026, 15:01Hassan Raza: The JAK2 V617F Revolution
-
Nov 11, 2026, 14:57Edward Lee Carter: Factor Xla Inhibition Enters Clinical Practice – FDA Approval of Asundexian